MedTrace Logo

The Experience of Giving Birth With Remifentanil for Pain Relief: A Qualitative Study of Mothers and Midwives

NCT07030777 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-04-07

No results posted yet for this study

Summary

Background:

Remifentanil is an ultra-short-acting opioid used for labor pain relief in several countries, offering stronger analgesia than nitrous oxide but less than epidural anesthesia. While internationally established, remifentanil has not yet been implemented in Denmark.

Objective:

This study aims to explore and deepen our understanding of the childbirth experience with remifentanil for pain relief, from both the birthing woman's and the midwife's perspectives.

Methods:

A qualitative study based on interviews with women who gave birth using remifentanil and the midwives involved in their care.

Conditions

  • Pain Management in Pregnant Women
  • Remifentanil
  • Midwife
  • Qualitative Research
  • Birth
  • Labour Analgesia

Sponsors & Collaborators

  • Nordsjaellands Hospital

    lead OTHER

Principal Investigators

  • Patricia Duch, MD · Department of Anaesthesia, Copenhagen University Hospital, North Zealand, Hillerød, Denmark

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07030777 on ClinicalTrials.gov